Filing Flows › biote (BTMD) › Q1 2025
biote (BTMD) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 9, 2025
biote (BTMD) reported revenue of $49.0M for the first quarter 2025 (Q1 2025), +5% from a year earlier and -2% from the quarter before. Operating margin was 19.8%, net earnings $13.7M (28.0% of revenue).
biote, Q1 2025: revenue $49.0M (+5% year over year), operating margin 19.8%, net earnings $13.7M, operating cash flow $6.5M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $49.0M | -2% | +5% |
| Operating profit | $9.7M | +250% | -7% |
| Net earnings | $13.7M | +270% | — |
| Operating cash flow | $6.5M | -48% | -12% |
| Free cash flow | $4.8M | -55% | -27% |
What changed
Revenue was $49.0M in Q1 2025, up 5% year over year and down 2% from the previous quarter. Pellet Procedures Product Revenue was the largest line at 74% of revenue. Dietary Supplements added $1.9M year over year (up 25%), 86% of the total change. Pellet Procedures Product Revenue declined 4%.
Operating profit was $9.7M, a 19.8% margin (down 2.5 points year over year). Operating profit fell $737K even though revenue rose $2.2M versus a year earlier, so costs grew faster than sales. Total costs grew 8% against revenue growth of 5%. The fastest-growing cost line was SG&A (+16%). Net earnings were $13.7M. The effective tax rate was 9.3%. Non-operating items added $7.8M, 44% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $6.5M (down 12% year over year), 41% of net income including minority interests. Non-cash charges added back $857K of depreciation and amortization and $2.1M of share-based compensation. Working capital and other items used $12.4M. Capital expenditures of $1.6M left free cash flow of $4.8M.
Questions
What was biote's revenue in the first quarter 2025?
biote (BTMD) reported revenue of $49.0M for the first quarter 2025 (Q1 2025), +5% from a year earlier and -2% from the quarter before.
Was biote profitable in the first quarter 2025?
Operating profit was $9.7M (19.8% of revenue) and net earnings $13.7M.
Source: biote 10-Q on SEC EDGAR.